Gridium Strengthens Balance Sheet with $14M in Funding to Accelerate Growth
Leading decarbonization firm for commercial real estate owners set to expand its SaaS footprint and…
Month: February 2023
Global Care Capital Announces Appointment of Chief Financial Officer
Vancouver, British Columbia–(Newsfile Corp. – February 23, 2023) – Global Care Capital Inc. (CSE: HLTH)…
Global Care Capital Announces Appointment of Chief Financial Officer
Vancouver, British Columbia–(Newsfile Corp. – February 23, 2023) – Global Care Capital Inc. (CSE: HLTH)…
Personas Announces the Spring 2023 Relaunch of the Keek Social Video Platform
Toronto, Ontario–(Newsfile Corp. – February 23, 2023) – Personas Social Incorporated (TSXV: PRSN) (the “Company”)…
Trintech’s Cadency V10.3 for SAP ERP Achieves SAP(R) Certified Integration with SAP NetWeaver(R)
DALLAS, TX, Feb 24, 2023 – (ACN Newswire) – Trintech, a leading global provider of…
Akeneo Expands Strategic Partnership with Google Cloud by Announcing Availability on Google Cloud Marketplace
The new offering will further empower merchants with the expanded ability to control inventory from…
Birdeye Adds ChatGPT Model to its AI Platform
Local brands and businesses can now automate review and survey responses with AI PALO ALTO,…
IQVIA Publishes its 2022 Environmental, Social and Governance Report
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA (NYSE:IQV) has published its 2022 Environmental, Social and Governance (ESG)…
Thales and LuxCarta sign a partnership to offer artificial intelligence powered solutions for military intelligence and cartography
Sophia Antipolis, France – February 23, 2023 – Thales and LuxCarta, a company specialized in…
Mount Graham Regional Medical Center selects HealthStore® to retire legacy systems & access historical patient data
WOBURN, MA – 23 February 2023 – Mount Graham Regional Medical Center (MGRMC), Arizona, has…
BioCorRx Attended 4th Annual NIH HEAL Initiative Investigator Meeting; Shares Update on BICX104 Data
ANAHEIM, CA, Feb. 23, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX)…
SciSparc Signs a Definitive Agreement to Sell 49% interest in its Subsidiary that Owns Wellution for $2.5 million
TEL AVIV, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or…
uniQure Announces HOPE-B Clinical Trial Data Published in the New England Journal of Medicine, Demonstrating Durability and Other Benefits of HEMGENIX® (etranacogene dezaparvovec-drlb)
~ Data follow the historic approval of the first gene therapy for hemophilia B, which…
Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission
WAKEFIELD, MA, Feb. 23, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the…
Patent Application Published for PharmAla Biotech’s MDMA Analogs
Patent covers 6 novel compositions of matter, which PharmAla has been studying in preclinical testing…
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma
Following the IND clearance, the Company is advancing into a Phase 1 clinical study Potentially…
Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update
Company Focuses on Development of Neuromuscular Blocking Agents Phase II Randomized Trial for BX1000 Initiated,…
Madrigal Pharmaceuticals Provides Corporate Updates and Reports 2022 Fourth Quarter and Full Year Financial Results
Positive Phase 3 MAESTRO-NASH study results reported in December 2022 position Madrigal for a resmetirom…
Enlivex Receives Clearance From Spanish Agency of Medicines and Medical Devices For Treatment of Patients with Advanced Solid Malignancies in the Ongoing Allocetra Phase I/II Clinical Trial
Nes-Ziona, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
Medigene Presents First Results for Automated Manufacturing of T Cell Receptor Engineered T Cells
MARTINSRIED, Germany and MUNICH, Germany, Feb. 23, 2023 (GLOBE NEWSWIRE) — Medigene AG (Medigene, FSE:…